<p>Groups of five mice were infected with <i>T. cruzi</i> trypomastigotes expressing luciferase and imaged on the indicated days after infection. Treatment with benznidazole (5 mg/kg/day, i.p.) started on day 4. (A) One representative mouse of each group is shown. (B) Quantification of luminescence signal from infected control or benznidazole treated mice. Results are expressed as average ± standard deviation (*, <i>P</i><0.05; **, <i>P</i><0.01).</p
<p>Mice (10 per group) were infected in the hind foot pads with 2.5×10<sup>5 </sup><i>T. cruzi</i> t...
<p>Mice were inoculated with 5000 trypomastigotes of <i>T. cruzi</i> CL, VL-10, or Colombian strains...
1<p>Swiss male mice weight 20 to 24 g inoculated with 10<sup>4</sup> blood trypomastigotes (Y strain...
<p>Groups of five mice were infected with <i>T. cruzi</i> and treated with different compounds follo...
45 BALB/c mice were infected with bioluminescent T. cruzi (strain CL Brener) (Methods). At day 101 p...
<p><b>A</b>. Schematic timeline of Bz treatment schedule of Swiss mice, infected with Colombiana str...
BALB/c mice were infected with bioluminescent T. cruzi (CL Brener strain) (Methods). 101 days post-i...
<p><b>A</b>. Schematic timeline of Bz treatment schedule of C57BL/6 mice, infected with Colombiana s...
<p>The activity of 5 (E–F), 12.5 and 25 (A–D) mg/Kg/day of DB1965 (ip) and 100 mg/kg/day DB1965 via ...
<p>Male BALB/c mice were infected in the oral cavity (<b>OI</b>) with 1x10<sup>6</sup> trypomastigot...
<p>(A) Mice (10 per group) were infected in the footpad with 1×10<sup>5 </sup><i>T. cruzi</i> biolum...
<p>Mice were inoculated with 5,000 <i>T</i>. <i>cruzi</i> Y strain trypomastigotes by the intraperit...
<p>C57BL/6 mice were infected i.p. with 10<sup>2</sup>,10<sup>3</sup>, 10<sup>4</sup> or 10<sup>5</s...
1<p>Swiss female (n = 10) weight 20 to 24 g were inoculated with 5×10<sup>3</sup> trypomastigotes (Y...
<p>Mice were infected with <i>T. cruzi</i> (1×10<sup>4</sup>) on day 0 and treated with the drugs (n...
<p>Mice (10 per group) were infected in the hind foot pads with 2.5×10<sup>5 </sup><i>T. cruzi</i> t...
<p>Mice were inoculated with 5000 trypomastigotes of <i>T. cruzi</i> CL, VL-10, or Colombian strains...
1<p>Swiss male mice weight 20 to 24 g inoculated with 10<sup>4</sup> blood trypomastigotes (Y strain...
<p>Groups of five mice were infected with <i>T. cruzi</i> and treated with different compounds follo...
45 BALB/c mice were infected with bioluminescent T. cruzi (strain CL Brener) (Methods). At day 101 p...
<p><b>A</b>. Schematic timeline of Bz treatment schedule of Swiss mice, infected with Colombiana str...
BALB/c mice were infected with bioluminescent T. cruzi (CL Brener strain) (Methods). 101 days post-i...
<p><b>A</b>. Schematic timeline of Bz treatment schedule of C57BL/6 mice, infected with Colombiana s...
<p>The activity of 5 (E–F), 12.5 and 25 (A–D) mg/Kg/day of DB1965 (ip) and 100 mg/kg/day DB1965 via ...
<p>Male BALB/c mice were infected in the oral cavity (<b>OI</b>) with 1x10<sup>6</sup> trypomastigot...
<p>(A) Mice (10 per group) were infected in the footpad with 1×10<sup>5 </sup><i>T. cruzi</i> biolum...
<p>Mice were inoculated with 5,000 <i>T</i>. <i>cruzi</i> Y strain trypomastigotes by the intraperit...
<p>C57BL/6 mice were infected i.p. with 10<sup>2</sup>,10<sup>3</sup>, 10<sup>4</sup> or 10<sup>5</s...
1<p>Swiss female (n = 10) weight 20 to 24 g were inoculated with 5×10<sup>3</sup> trypomastigotes (Y...
<p>Mice were infected with <i>T. cruzi</i> (1×10<sup>4</sup>) on day 0 and treated with the drugs (n...
<p>Mice (10 per group) were infected in the hind foot pads with 2.5×10<sup>5 </sup><i>T. cruzi</i> t...
<p>Mice were inoculated with 5000 trypomastigotes of <i>T. cruzi</i> CL, VL-10, or Colombian strains...
1<p>Swiss male mice weight 20 to 24 g inoculated with 10<sup>4</sup> blood trypomastigotes (Y strain...